• In late April 2026, IMAX Corporation reported first-quarter 2026 results showing revenue of US$81.38 million and net income of US$4.23 million, while also highlighting a completed share repurchase program and no additional buybacks in the quarter.
• A key development was IMAX and HOYTS Cinemas’ agreement for ten new IMAX with Laser locations across Australia and New Zealand, nearly doubling IMAX’s Australian footprint and underscoring the company’s push into high-performing premium cinema markets.
• Next, we’ll examine how the HOYTS expansion and packed IMAX blockbuster slate interact with the existing investment narrative for IMAX.

Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

IMAX Investment Narrative Recap

To own IMAX today, you have to believe premium theatrical experiences can keep drawing audiences even as at home options improve, and that a strong blockbuster pipeline will support its global network expansion. The HOYTS deal and Q1 2026 results modestly reinforce that near term catalyst: more high performing premium screens tied to filmmaker friendly event movies. The biggest risk remains heavy dependence on tentpole content and premium formats competition, which this quarter’s Infinity Vision spat with Disney underlines but does not materially change.

The HOYTS expansion across Australia and New Zealand directly ties into IMAX’s core catalyst of growing its high per screen markets. Moving from four to fourteen HOYTS locations over the next few years, on top of record Australian box office in 2025, aligns with management’s focus on installation driven earnings power and a fuller blockbuster slate. It also sits alongside IMAX’s guidance for record US$1.4 billion global box office in 2026 as the company leans into Filmed For IMAX titles.

Yet even with these positives, investors should be aware that competition from alternative premium formats and changing moviegoer habits could...

IMAX's narrative projects $501.5 million revenue and $91.4 million earnings by 2029. This requires 6.9% yearly revenue growth and about a $56.5 million earnings increase from $34.9 million today.

Uncover how IMAX's forecasts yield a $45.27 fair value, a 27% upside to its current price.

Exploring Other Perspectives

By contrast, the most pessimistic analysts were already assuming only about US$499 million of revenue by 2029 and see home cinema trends eroding IMAX’s edge, so the HOYTS deal and Q1 results could either soften or reinforce that cautious view depending on how you weigh theatrical momentum against shifting audience behavior.

Explore 3 other fair value estimates on IMAX - why the stock might be worth just $45.27!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your IMAX research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free IMAX research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate IMAX's overall financial health at a glance.

No Opportunity In IMAX?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• We've uncovered the 13 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.